Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0000950170-25-020272

President and CEO sold 215,506 shares at an average $3.80 ($818,400)

  • President and CEO acquired 332,465 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Sanjiv · President and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-11 Sale : show line 1 in the form −140,182 $3.85 $539,701 625,948 D
2025-02-11 Grant or award : show line 2 in the form +332,465 958,413 D
2025-02-13 Sale : show line 3 in the form −75,324 $3.70 $278,699 883,089 D
Open-market sales · 215,506 sh · avg $3.80 · $818,400
Loading xslF345X05/ownership.xml…